GZD824 Dimesylate
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl (WT) and Bcr-Abl (T315I) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
724.77
Molecular Formula
C29H27F3N6O·2CH4O3S
Notes
Research use only, not for human use.
Receptor
Abl| Abl (E255K) | Abl (H396P) | Abl (M351T) | Abl (Q252H)
CAS Number
1421783-64-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IRTAMSCD54YN1174CPECY55100 100 Tests
Anti Mouse CD54 Flow Cytometry Monoclonal Clone YN1174 PE/Cyanine5.5 Ready To Use 100 Tests
Ask
View Details MBS1346308-01 0.02 mg (E-Coli)
Recombinant Xanthomonas campestris pv. campestris Phosphoribosylglycinamide formyltransferase 2 (purT)
Ask
View Details MBS1346308-02 0.02 mg (Yeast)
Recombinant Xanthomonas campestris pv. campestris Phosphoribosylglycinamide formyltransferase 2 (purT)
Ask
View Details 
MBS1346308-03 0.1 mg (E-Coli)
Recombinant Xanthomonas campestris pv. campestris Phosphoribosylglycinamide formyltransferase 2 (purT)
Ask
View Details 
MBS1346308-04 0.1 mg (Yeast)
Recombinant Xanthomonas campestris pv. campestris Phosphoribosylglycinamide formyltransferase 2 (purT)
Ask
View Details MBS1346308-05 0.02 mg (Baculovirus)
Recombinant Xanthomonas campestris pv. campestris Phosphoribosylglycinamide formyltransferase 2 (purT)
Ask
View Details